Status:
RECRUITING
Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Parkinson Disease
Eligibility:
All Genders
40-65 years
Brief Summary
REM sleep behavior disorder is a novel and distinct parasomnia characterized by recurrent dream enactment behaviors (DEBs) and polysomnographic features of REM sleep without atonia (RSWA), with typica...
Detailed Description
Idiopathic RBD (iRBD) as a specific prodromal marker of α-synucleinopathy Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by abnormal behavioral manifestations and...
Eligibility Criteria
Inclusion
- Chinese aged 40 or above
- Can give informed consent for participation in the study
- Sex- and age matched between groups
Exclusion
- younger than 40
- not capable of giving informed consent for participation in the study
Key Trial Info
Start Date :
January 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 2 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05353959
Start Date
January 3 2022
End Date
January 2 2025
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shatin Hospital
Shatin, Hong Kong